Overcoming challenges associated with performing bioburden and other purity tests for microbiome based therapeutics

Time: 4:00 pm
day: Day One


  • Microbiome therapeutic products are changing the future of medicine as we know it. Bioburden and other tests for purity of therapeutic products are required by regulatory agencies in order to ensure the safety of patients
  • However, these tests often have challenges due to the fact that most microbiome based therapeutics are composed of live biotherapeutic organisms. This presentation will dive into the microbial tests for purity that are commonly conducted for microbiome based therapeutics, the common issues observed during execution of these tests and how to overcome these challenges